IN2013MU01111A - - Google Patents

Info

Publication number
IN2013MU01111A
IN2013MU01111A IN1111MU2013A IN2013MU01111A IN 2013MU01111 A IN2013MU01111 A IN 2013MU01111A IN 1111MU2013 A IN1111MU2013 A IN 1111MU2013A IN 2013MU01111 A IN2013MU01111 A IN 2013MU01111A
Authority
IN
India
Prior art keywords
ticagrelor
preparation
pharmaceutically acceptable
relates
acceptable salts
Prior art date
Application number
Inventor
G Bhatt Navin
Naik Samir
Kumar Sharma Ajay
Choraghe Mahendra
Bhaskar Bhirud Shekhar
Original Assignee
Glenmark Generics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Generics Ltd filed Critical Glenmark Generics Ltd
Priority to IN1111MU2013 priority Critical patent/IN2013MU01111A/en
Priority to PCT/IN2014/000165 priority patent/WO2014155389A2/en
Publication of IN2013MU01111A publication Critical patent/IN2013MU01111A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to a process for the preparation of ticagrelor and pharmaceutically acceptable salts thereof.
IN1111MU2013 2013-03-25 2014-03-14 IN2013MU01111A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN1111MU2013 IN2013MU01111A (en) 2013-03-25 2014-03-14
PCT/IN2014/000165 WO2014155389A2 (en) 2013-03-25 2014-03-14 Process for preparation of ticagrelor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1111MU2013 IN2013MU01111A (en) 2013-03-25 2014-03-14

Publications (1)

Publication Number Publication Date
IN2013MU01111A true IN2013MU01111A (en) 2015-05-01

Family

ID=51625566

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1111MU2013 IN2013MU01111A (en) 2013-03-25 2014-03-14

Country Status (2)

Country Link
IN (1) IN2013MU01111A (en)
WO (1) WO2014155389A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105801583A (en) * 2014-12-31 2016-07-27 徐州万邦金桥制药有限公司 Purification method of ticagrelor
CN109633063B (en) * 2018-12-26 2021-05-04 哈尔滨医科大学 Method for detecting concentration of ticagrelor and active metabolite thereof in human plasma
CN112394109A (en) * 2019-08-12 2021-02-23 武汉武药科技有限公司 Method for detecting impurities in ticagrelor
CN110642862B (en) * 2019-10-29 2021-01-26 株洲千金药业股份有限公司 Preparation method of ticagrelor ethylated impurity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI229674B (en) * 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB0013407D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Forms of a chemical compound
CA2832570A1 (en) * 2011-04-06 2012-10-11 Teva Pharmaceutical Industries Ltd. New intermediates and processes for preparing ticagrelor
CN102731467B (en) * 2011-04-15 2015-12-16 博瑞生物医药（苏州）股份有限公司 The intermediate of ADZ6140 and prepare the method for ADZ6140
CN102603751A (en) * 2012-02-24 2012-07-25 中国药科大学 Triazol (4,5-D) pyrimidine derivate and preparation method of triazol (4,5-D) pyrimidine derivate as well as application of triazol (4,5-D) pyrimidine derivate in drug preparation
CN102875537A (en) * 2012-09-10 2013-01-16 常州制药厂有限公司 Novel preparation method of antithrombosis medicine

Also Published As

Publication number Publication date
WO2014155389A3 (en) 2015-01-15
WO2014155389A2 (en) 2014-10-02

Similar Documents

Publication Publication Date Title
PH12016501122A1 (en) Delayed release compositions of linaclotide
IN2014CH00247A (en)
MX370649B (en) Process for the preparation of teneligliptin.
IL245524A0 (en) New methods to produce active tert
IN2013MU00646A (en)
MX2014010433A (en) Novel crystalline form of sitagliptin sulfate.
EP3014628B8 (en) Process of generating germanium-68
IN2013MU03641A (en)
IL245474B (en) Process for the preparation of 5-fluoro-1h-pyrazoles
IL245649A0 (en) A process for the preparation of regadenoson
IL245476A0 (en) Process for the preparation of 5-fluoro-1h-pyrazoles
IN2013MU03070A (en)
PT3052466T (en) Process for the preparation of xanthohumol
IN2013MU01111A (en)
IN2013MU01113A (en)
IL229326A (en) Process for the preparation of n-iodoamides
HUP1300033A2 (en) Improved process for producing pharmaceutical agent and intermediate
IN2013CH04314A (en)
IN2013MU02528A (en)
MX2017007510A (en) A process for the manufacture of idalopirdine.
IN2014CH01391A (en)
WO2014147464A3 (en) Novel process for the preparation of tolcapone
IN2013MU03768A (en)
IN2013MU01226A (en)
IN2013CH03945A (en)